Advancis Pharmaceutical Corporation, a Germantown-based pharmaceutical company focusing on developing and commercializing novel anti-infective products, reported full-year 2006 revenue totaled $4.8 million compared with full-year 2005 revenues of $16.8 million.
Product sales from the company?s Keflex and antibiotics made up all of the company?s revenue in 2006 and were $4.8 million for the year, the same as product sales from 2005.
Recommended Stories
Print subscriber? Click here to login/register your account
Digital subscriber? Click here to login/register your account.